Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer·2020
Same author

Effects of a Four-Day Mindfulness Intervention on Teachers' Stress and Affect: A Pilot Study in Eastern China.

Frontiers in psychology·2020
Same author

Photoacoustic Detection of H<sub>2</sub> and NH<sub>3</sub> Using Plasmonic Signal Enhancement in GaN Microcantilevers.

Micromachines·2020
Same author

ELT-2 promotes O-GlcNAc transferase OGT-1 expression to modulate Caenorhabditis elegans lifespan.

Journal of cellular biochemistry·2020
Same author

Gender difference of association between plasma N-terminal pro-atrial natriuretic peptide and metabolic syndrome.

Hormones (Athens, Greece)·2020
Same author

Identification of <i>N</i>-Phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-amine Derivatives as Novel, Potent, and Selective NF-κB Inducing Kinase (NIK) Inhibitors for the Treatment of Psoriasis.

Journal of medicinal chemistry·2020

相关实验视频

Updated: May 11, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.2K

优化除器部署与安装在公共汽车上的自动化外部除器.

Hongmei Li1, Ying Wu1, Taibo Luo2

  • 1School of Economics and Management, Northwest University, Xi'an, P. R. China.

Prehospital emergency care
|August 14, 2024
PubMed
概括

结合固定式和装在公共汽车上的自动外部除器 (AED),显著改善了医院外心脏骤停 (OHCA) 事件的覆盖范围. 当AED资源有限时,这种策略特别有效,提高了生存率.

科学领域:

  • 公共卫生 公共卫生
  • 紧急医疗服务 紧急医疗服务
  • 运营研究 运营研究

背景情况:

  • 早期除对于医院外心脏骤停 (OHCA) 的生存至关重要.
  • 固定式自动外部除器 (S-AEDs) 的覆盖范围有限.
  • 安装在公共汽车上的自动化外部除器 (B-AEDs) 提供更广泛的覆盖范围,但具有操作时间限制.

研究的目的:

  • 为部署S-AED和B-AED开发一个优化的模型.
  • 为了最大限度地提高OHCA事件的需求点的总覆盖水平.
  • 为了确定B-AED和S-AED的最佳数量和放置,给定了设备的固定总数.

主要方法:

  • 根据p-中位数问题 (JPMP) 提出了B-AED和S-AED的联合位置模型.
  • 利用来自中国安市安区的数据进行部署分析.
  • 将JPMP性能与其他位置模型进行比较,并分析了覆盖范围的影响.

主要成果:

  • 根据JPMP模型,覆盖的需求点平均增加了98.43%,总覆盖水平增加了74.05%.
  • 最佳的B-AED覆盖率与可用的AED数量呈现出一个反转的U形关系.
  • 通过特定的巴士出发间隔,最大限度地覆盖总覆盖范围,随着AED可用性增加,这些间隔会减少.

更多相关视频

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.4K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

440

相关实验视频

Last Updated: May 11, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.2K
Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.4K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

440

结论:

  • 联合部署S-AED和B-AED显著提高了OHCA的覆盖范围.
  • 当AED数量不足时,强烈建议使用B-AED.
  • 对S-AED和B-AED的最佳放置可以提高公共安全结果.